Passive immune globulin therapy in the SIV/macaque model: Early interventisn can alter disease profile

Immunology Letters

Volumn 51, Issue 1-2, 1996, Pages 107-114

  Haigwood, Nancy L ^a   Watson, Andrew ^a   Sutton, William F ^a   McClure, Jan ^a   Lewis, Anne ^b   Ranchalis, Jane ^a   Travis, Bruce ^a   Voss, Gerald ^c   Letvin, Norman L ^c   Hu, Shiu Lok ^a   Hirsch, Vanessa M ^d   Johnson, Philip R ^b  

^a BRISTOL MYERS SQUIBB PHARMACEUTICAL RESEARCH INSTITUTE   (United States)

^b NATIONWIDE CHILDREN S HOSPITAL   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

AIDS; HIV therapy; Humoral immune responses; Long term non progressors; Passive antibody therapy; Primate lentiviruses; RT QC PCR; SIV macaque model

Indexed keywords

IMMUNOGLOBULIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; HUMORAL IMMUNITY; MACACA; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; TREATMENT OUTCOME;

EID: 0030175872     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-2478(96)02563-1     Document Type: Conference Paper

References (22)

1. [1] Ho, D.D., Neumann, A.U., Perelson, A.S., Chen, W., Leonard, J.M. and Markowitz, M. (1995) Nature 373, 123.
2. [2] Wei, X., Ghosh, S.K, Taylor, M.E., Honson, V.A., Emini, E.E., Deutsch, P., Lifson, J.D., Bonhoeffer, S., Nowak, M.A., Hahn, B.H. Saag, M.S. and Shaw, G.M. (1995) Nature 373, 364.
3. [3] Hu, S.-L., Haigwood, N.L. and Morton, W.R. (1994) in: HIV Molecular Organization, Pathogenicity and Treatment (W.J.W. Morrow and N.L. Haigwood, Eds.) pp. 293-327, Elsevier, Amsterdam.
4. [4] Haigwood, N.L., Weiser, B. and Burger, H. (1994) in: HIV Molecular Organization, Pathogenicity and Treatment (W.J.W. Morrow and N.L. Haigwood, Eds.) pp. 329-363, Elsevier, Amsterdam.
5. [5] Steimer, K.S, Scandella, C.J., Skiles, P.V. and Haigwood, N.L. (1991) Science 254, 105.
6. [6] Haigwood, N.L., Misher, L.E., Chin, S.M., Blair, M., Planelles, V., Scandella, C.J., Steimer, K.S., Gardner, M.B. Yilma, T., Hirsch, V.M. and Johnson, P.R. (1992) J. Med. Primatol. 21, 82.
7. [7] Johnson, P.R., Montefiori, D.C., Goldstein, S., Hamm, T.E., Zhou, J., Kitov, S., Haigwood, N.L., Misher, L., London, W.T., Gerin, J.L., Allison, A., Purcell, R.H., Chanock, R.M. and Hirsch, V.M. (1992) Proc. Natl. Acad. Sci USA 89, 2175.
8. [8] Vittecoq, D., Mattlinger, B., Barre-Sinoussi, F., Courouce, A.M., Rouzioux, C., Doinel, C., Bary, M., Viard, J.P., Bach, J.F., Rouger, P. and Lefrere, J.J. (1992) J. Infect. Dis. 165, 364
9. [9] Jacobson, J.M., Colman, N., Ostrow, N.A., Simson, R.W., Tomesch, D.M., Marlin, L., Rao, M., Mills, J.L., Clemens, J. and Prince, A.M. (1993) J. Infect. Dis. 168, 298.
10. [10] Karpas, A., Hill, F., Youle, M., Cullen, V., Gray, J., Byron, N., Hayoe, F., Tenant-Flowers, M., Howard, L., Gilgen, D., Oates, J.K., Hawkins, D. and Gazzard, B. (1988) Proc. Natl. Acad. Sci. USA 85, 9234.
11. [11] Vittecoq, D., Chevret, S., Morand-Joubert, L., Heshmatt, F., Audat, F., Bary, M., Dusautoir, T., Bismuth, A., Viard, J.P., Barre-Sinoussi, F., Bach, J.F. and Lefrere, J.J. (1995) Proc. Natl. Acad. Sci. USA 92, 1195.
12. [12] Ho, D.D. (1995) N. Engl. J. Med. 333, 450.
13. [13] Goldstein, S., Elkins, W.R., London, W.T., Hahn, A., Goeken, R., Martin, J.E. and Hirsch, V.M. (1994) J. Med. Primatol. 23, 75.
14. [14] Hogevorst, F., Jurriaans, S., de Wolf, L.f., van Wijk, A., Wiersma, A., Valk, M., Roos, M., van Genien, B, Coutinho, R., Miedema, F. and Goudsmit, J. (1995) J. Infect. Dis. 171, 811.
15. [15] Cao, Y., Qin, L., Zhang, L., Safrit, J. and Ho, D.D. (1995) N. Engl. J. Med. 332, 201.
16. [16] Haigwood, N.L., Watson, A., McClure, J., Sutton, W.F., Ranchalis, J., Travis, B., Hu, S.-L., Hirsch, V.M., Voss, G., Letvin, N.L., Lewis, A. and Johnson, P.R. (1995) in: Vaccines95 (R.M. Chanock, F. Brown, H.S. Ginsberg and E. Norrby, Eds.) pp. 149-158, Cold Spring Harbor Laboratory Press, New York.
17. [17] Chackerian, B., Haigwood, N.L. and Overbaugh, J. (1995) Virology, in press.
18. [18] Putkonen, P., Thorstensson, R., Ghavemzadeh, L., Albert, J., Hild, K., Biberfeld, G. and Norrby, E. (1991) Nature 352, 436.
19. [19] Lewis, M.G., Elkins, W.R., McCutchan, F.E., Benveniste, R.E., Lai, C.-Y., Montefiori, D.C., Burke, D.S., Eddy, G.A. and Shafferman, A. (1993) Vaccine 11, 1347.
20. [20] Kent, K.A., Kitchin, P., Mills, K.H.G., Page, M., Taffs, F., Corcoran, T., Silvera, P., Flanagan, B., Powell, C., Rose, J., Ling, C., Aubertin, A.M. and Stott, E.J. (1994) AIDS Res. Hum. Retrovir. 10, 189.
21. [21] Prince, A.M., Reesink, H., Pasual, D., Horowitz, B., Hewlett, I., Murthy, K.K., Cobb, K.E. and Eichberg, J.W. (1991) AIDS Res. Hum. Retrovir. 7, 971.
22. [22] Hohdatsu, T., Pu, R., Torres, B.A., Trujillo, S., Gardner, M.B. and Yamamoto, J.K. (1993) J. Virol. 67, 2344.